Professor Didier Houssin appointed as Chairman of ANSES's Board of Administrators
The news has been added to your library
News of 04/12/2013
Currently Chairman of the French Agency for the Assessment of Research and Higher Education (AERES), Professor Didier Houssin has been appointed Chairman of the Board of Administrators of the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) by a Decree of the President of the French Republic dated 2 December 2013.
Didier Houssin, a medical doctor and professor of surgery, began his career in surgery as an intern and then as an assistant clinical head in the Hôpitaux de Paris public hospital system from 1973 to 1982. He then joined INSERM(1) as a research fellow, where he worked until 1988. Appointed as the director general of the Etablissement français des greffes (French transplant agency) in 1994, he then was made head of the surgery department of Hôpital Cochin, where he worked for 5 years until he was called in 2003 to head the medical policy department of Assistance Publique-Hôpitaux de Paris.
In 2005, he was appointed director general of health and interministerial delegate for avian flu control, and then in 2011 as chairman of the French Agency for Research and Higher Education Assessment (AERES), a position which he still holds today.
As an advisor for the World Health Organization (WHO), and the author of over 300 scientific publications and an essay on the topic of emergencies, he was made an Officer of the French National Order of the Legion of Honour in 2008, and in 2012 received the French Medal of Honour for health and social affairs.
During his hearing by the French Parliament, Didier Houssin identified four major challenges to be taken on by ANSES's Board of Administrators, which was renewed on 22 November: "Ensure the independence and scientific credibility of the Agency's work, maintain the consistency of its assignments and resources while maintaining a productive relationship with its supervisory ministries, pursue the initiatives of transparency and openness to society begun by the Agency, and accentuate the Agency's European and international positioning".
(1)Institut national de la santé et de la recherche médicale [National Institute of Health and Medical Research]